Intelligent Bio Solutions Inc.INBSNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank56
5Y CAGR-62.6%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-62.6%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 7.39% |
| Q3 2025 | -66.60% |
| Q2 2025 | 306.22% |
| Q1 2025 | -29.31% |
| Q4 2024 | -46.57% |
| Q3 2024 | 26.48% |
| Q2 2024 | 59.15% |
| Q1 2024 | 35.26% |
| Q4 2023 | 235.22% |
| Q3 2023 | -18.19% |
| Q2 2023 | -57.63% |
| Q1 2023 | 25080.35% |
| Q4 2022 | -98.50% |
| Q3 2022 | -88.55% |
| Q2 2022 | 67.57% |
| Q1 2022 | -84.35% |
| Q4 2021 | 2373.04% |
| Q3 2021 | -91.83% |
| Q2 2021 | -39.40% |
| Q1 2021 | 530.83% |
| Q4 2020 | 1004.85% |
| Q3 2020 | -34.43% |
| Q2 2020 | -19.79% |
| Q1 2020 | -88.11% |
| Q4 2019 | 370.30% |
| Q3 2019 | -95.24% |
| Q2 2019 | 412.58% |
| Q1 2019 | 568.00% |
| Q4 2018 | -93.46% |
| Q3 2018 | 0.49% |
| Q2 2018 | 38.66% |
| Q1 2018 | -9.97% |
| Q4 2017 | 100.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |